Title
Comparison of efficacy, safety, and cost of low-molecular-weight heparin with continuous-infusion unfractionated heparin for initiation of anticoagulation after mechanical prosthetic valve implantation
UMMS Affiliation
Department of Quantitative Health Sciences
Publication Date
2004-01-13
Document Type
Article
Subjects
Anticoagulants; Case-Control Studies; Female; *Heart Valve Prosthesis Implantation; Heparin; Heparin, Low-Molecular-Weight; Hospital Costs; Humans; Infusions, Intravenous; Length of Stay; Male; Middle Aged; Safety; Warfarin
Disciplines
Biostatistics | Epidemiology | Health Services Research
Abstract
We compared the efficacy, safety, and impact on postoperative hospital length of stay and inpatient hospital costs of low-molecular-weight heparin with that of unfractionated heparin as a "bridge" to achieving therapeutic levels of anticoagulation with warfarin in patients with newly implanted prosthetic heart valves. The patients who received low-molecular-weight heparin had a shorter length of stay and decreased postoperative costs compared with the control subjects receiving unfractionated heparin.
Source
Am J Cardiol. 2004 Jan 15;93(2):247-50.
Journal/Book/Conference Title
The American journal of cardiology
PubMed ID
14715362
Related Resources
Repository Citation
Fanikos J, Tsilimingras K, Kucher N, Rosen AB, Hieblinger MD, Goldhaber SZ. (2004). Comparison of efficacy, safety, and cost of low-molecular-weight heparin with continuous-infusion unfractionated heparin for initiation of anticoagulation after mechanical prosthetic valve implantation. Population and Quantitative Health Sciences Publications. Retrieved from https://escholarship.umassmed.edu/qhs_pp/889